Alkem Laboratories announced the launch of Renocia cyclical therapy kit, a scientifically-designed weekly nutritional supplementation regimen to support hair growth, strengthen hair follicles and manage hair loss. The supplements in the kit are made using only vegetarian-sourced ingredients. Renocia cyclical therapy kit contains a set of nutritional supplements, including vitamins, minerals, and amino acids, each to be taken on designated days of the week. This structured weekly protocol enables better nutrient absorption and utilisation. Alkem has a growing portfolio of products in the dermatology segment, which includes skin and hair care. Under the Renocia brand, the company offers several products for hair care such as hair revitalizing shampoo, conditioner and serum, as well as oral supplements. Powered by Capital Market - Live News

Alkem Laboratories announced that Rakesh Tripathi, a Senior Management Personnel has tendered his resignation from the services of the Company on account of personal commitments effective from 08 December 2025.Powered by Capital Market - Live News

Alkem Laboratories announced that Prakash Ramnani has been appointed at senior management position in the Company effective from 05 December 2025.Powered by Capital Market - Live News

Net profit of Alkem Laboratories rose 11.10% to Rs 765.06 crore in the quarter ended September 2025 as against Rs 688.64 crore during the previous quarter ended September 2024. Sales rose 17.17% to Rs 4000.99 crore in the quarter ended September 2025 as against Rs 3414.67 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales4000.993414.67 17 OPM %23.0122.05 - PBDT989.44859.17 15 PBT895.83780.26 15 NP765.06688.64 11 Powered by Capital Market - Live News

 Alkem Foundation, the Corporate Social Responsibility (CSR) arm of Alkem Laboratories (Alkem), and Indian Institute of Technology Bombay (IIT Bombay) today announced a strategic collaboration to set up a first-of-its-kind research centre in India dedicated to immuno-therapeutics and regenerative medicines. Under this collaboration, Alkem Foundation will fund the establishment of �Alkem Centre for Advanced Research and Development of Applied Immuno-Therapeutics and Regenerative Medicines� in the IIT Bombay campus. This is a pioneering step in fostering cutting-edge research and innovation in complex disease areas, which have significant unmet medical needs. Alkem Foundation will contribute a substantial 20-25% of its cumulative CSR obligations over seven years on this research centre. This is the first industry-academia collaboration in the country, initiated through the CSR route, for advancing research in the areas of immuno-therapeutics and regenerative medicines. The partnership brings together Alkem`s pharmaceutical industry insights and experience in developing healthcare solutions, and IIT Bombay`s expertise in biomedical engineering, biosciences, and translational research, along with a pool of globally trained faculty, to create a distinctive innovation and translation ecosystem. Powered by Capital Market - Live News